Smita Kumari
Biochemistry, Genetics and Molecular Biology · The Ohio State University
Publications
18
Citations
536
Est. group size
—
Recurring co-author estimate
Active years
31
Publishing since 1996
Smita Kumari's work focuses on the molecular biology of cancers such as glioblastoma multiforme (an aggressive brain tumor) and neuroblastoma, examining tumor microenvironments, resistance to treatment, and potential biomarkers and therapies. Recent work also extends into neurological conditions like multiple sclerosis and Parkinson's disease, and into environmental health topics such as the neurotoxic effects of micro- and nanoplastics. Much of this research is presented as literature reviews synthesizing molecular mechanisms and emerging therapeutic strategies rather than solely original experimental studies.
Publication output has been irregular over the past decade, with several years of no recorded output followed by a marked increase in activity from 2021 through 2026.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Integrating Molecular Pathology, Tumor Microenvironment, and Novel Therapies to Overcome Resistance in Glioblastoma
Journal of Molecular Neuroscience · 2026
- Tumor suppressor network dysregulation in neuroblastoma: molecular mechanisms and precision therapeutic opportunities
Frontiers in Cell and Developmental Biology · 2026
- Deciphering the Neurotoxic Burden of Micro- and Nanoplastics: From Multi-model Experimental Evidence to Therapeutic Innovation
Molecular Neurobiology · 2025
- Decoding the molecular and cellular aspects of multiple sclerosis: From diagnosis to therapeutic strategies
Brain Research · 2025
- New era of artificial intelligence and machine learning-based detection, diagnosis, and therapeutics in Parkinson’s disease
Ageing Research Reviews · 2023
- Multiple therapeutic approaches of glioblastoma multiforme: From terminal to therapy
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2023
- Emerging trends in post-translational modification: Shedding light on Glioblastoma multiforme
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2023
- Design and Computational Analysis of an MMP9 Inhibitor in Hypoxia-Induced Glioblastoma Multiforme
ACS Omega · 2023
- Identification and characterization of putative biomarkers and therapeutic axis in Glioblastoma multiforme microenvironment
Frontiers in Cell and Developmental Biology · 2023
- Combinatorial therapy in tumor microenvironment: Where do we stand?
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2021
- Unboxing the molecular modalities of mutagens in cancer
Environmental Science and Pollution Research · 2021
- Precision Oncology, Signaling, and Anticancer Agents in Cancer Therapeutics
Anti-Cancer Agents in Medicinal Chemistry · 2021
- Activation of Epithelial-Mesenchymal Transition and Altered β-Catenin Signaling in a Novel Indian Colorectal Carcinoma Cell Line
Frontiers in Oncology · 2019
- Biochimica et Biophysica Acta (BBA) - Reviews on Cancer×3
- Cancers×2
- Frontiers in Cell and Developmental Biology×2
- Ageing Research Reviews×1
- Environmental Science and Pollution Research×1
- Mircea Ivan
Biochemistry, Genetics and Molecular Biology · Indiana University
- Yanlin Jiang
Biochemistry, Genetics and Molecular Biology · Indiana University
- Russell R. Lonser
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Ying Meng
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Yizhen Guo
Biochemistry, Genetics and Molecular Biology · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile